Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Download references

This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor

Highly Accessed

Erosive arthritis

Georg Schett

Arthritis Research & Therapy 2007, 9(Suppl 1):S2  doi:10.1186/ar2166

Include


Format